GSK Ownership | Who Owns GSK?
GSK Ownership Summary
GSK is owned by 9.28% institutional investors, 0.06% insiders, and 90.65% retail investors. Dodge & cox is the largest institutional shareholder, holding 1.94% of GSK shares. Dodge & Cox Stock I is the top mutual fund, with 2.88% of its assets in GSK shares.
GSK Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | GSK | 9.28% | 0.06% | 90.65% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Drug Manufacturers - General Stocks | 50.22% | 2.50% | 47.29% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Dodge & cox | 78.76M | 1.94% | $3.02B |
| Fmr | 52.82M | 1.29% | $1.79B |
| Fisher asset management | 31.34M | 0.77% | $1.20B |
| Primecap management co/ca/ | 27.73M | 0.68% | $1.06B |
| Jtc employer solutions trustee | 15.00M | 0.37% | $575.67M |
| Morgan stanley | 10.11M | 0.25% | $389.18M |
| Goldman sachs group | 9.68M | 0.24% | $327.48M |
| Price t rowe associates inc /md/ | 7.57M | 0.19% | $255.91M |
| Royal bank of canada | 7.17M | 0.18% | $242.46M |
| State street | 6.80M | 0.17% | $264.46M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Jtc employer solutions trustee | 15.00M | 54.90% | $575.67M |
| Eversept partners, lp | 2.24M | 7.92% | $86.11M |
| Krensavage asset management | 271.73K | 5.52% | $10.43M |
| Kahn brothers group | 659.87K | 5.09% | $25.34M |
| Equity investment | 4.19M | 3.53% | $161.00M |
| Mondrian investment partners | 5.84M | 3.40% | $205.92M |
| Hillman capital management | 152.60K | 3.20% | $5.86M |
| Keystone financial planning | 229.12K | 2.66% | $8.80M |
| Yelin lapidot management | 364.05K | 2.55% | $13.98M |
| Callodine capital management, lp | 598.52K | 2.38% | $22.98M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 52.82M | 0.11% | 23.81M |
| Ubs group | 6.48M | 0.04% | 5.82M |
| Goldman sachs group | 9.68M | 0.05% | 2.31M |
| Primecap management co/ca/ | 27.73M | 0.84% | 2.02M |
| Alyeska investment group | 3.16M | 0.43% | 1.42M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Provident trust | - | - | -3.95M |
| Camber capital management lp | - | - | -2.50M |
| Morgan stanley | 10.11M | 0.03% | -2.36M |
| Voloridge investment management | - | - | -2.17M |
| Arrowstreet capital, limited partnership | - | - | -1.49M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Kahn brothers group | 659.87K | 5.09% | 659.87K | $25.34M |
| Bnp paribas arbitrage, snc | 367.31K | 0.01% | 367.31K | $12.42M |
| Kranot hishtalmut le morim ve gananot havera menahelet | 336.62K | 0.91% | 336.62K | $11.58M |
| Walled lake planning & wealth management | 119.51K | 1.50% | 119.51K | $4.04M |
| Kranot hishtalmut le morim tichoniim havera menahelet | 115.39K | 0.95% | 115.39K | $3.97M |
Sold Out
| Holder | Change |
|---|---|
| Northwest financial advisors | -1.00 |
| Caitlin john | -2.00 |
| West branch capital | -7.00 |
| Aspire private capital | -7.00 |
| Operose advisors | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 894 | 2.41% | 377,213,995 | 3.29% | 9 | 11.59% | 467 | 11.46% | 249 | -9.78% |
| Mar 31, 2025 | 865 | -0.12% | 365,007,895 | 7.05% | 8 | 12.81% | 415 | 6.41% | 275 | -13.52% |
| Dec 31, 2024 | 507 | -44.83% | 114,357,926 | -62.96% | 2 | 1.22% | 223 | -43.97% | 181 | -42.54% |
| Sep 30, 2024 | 907 | 1.80% | 308,475,315 | -0.74% | 15 | 6.51% | 392 | 2.08% | 310 | 2.99% |
| Jun 30, 2024 | 873 | -5.72% | 308,017,843 | -1.01% | 7 | 12.95% | 377 | -11.71% | 293 | -2.01% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Dodge & Cox Stock I | 58.41M | 2.88% | - |
| Vanguard PRIMECAP Inv | 19.89M | 0.99% | 1.77M |
| Strategic Advisers Fidelity US TtlStk | 7.41M | 0.37% | 42.40K |
| GMO Intl Op Value Composite | 7.03M | 0.35% | 7.03M |
| Dodge & Cox Balanced Composite | 5.42M | 0.27% | -90.00K |
| Dodge & Cox Balanced I | 5.42M | 0.27% | -90.00K |
| Fidelity Series Value Discovery | 4.38M | 0.22% | - |
| T. Rowe Price International Val Eq Tr- A | 4.16M | 0.21% | 137.06K |
| Fidelity Equity Dividend Income | 4.04M | 0.20% | 927.80K |
| Fidelity Series Large Cap Stock | 3.81M | 0.19% | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2023 Q1 | - | - |
| 2022 Q4 | - | - |
| 2021 Q3 | 1 | - |
| 2021 Q2 | - | - |
| 2018 Q3 | 1 | - |
GSK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools